Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 20, 2023, titled "Glenmark Pharmaceuticals receives ANDA approval for Prochlorperazine MaleateTablets USP, 5 mg and 10 mg".
Glenmark Pharmaceuticals Limited Press Release Mar 20 2023
Filed with NSE · · 2 pages · English
Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6Read the transcript of Glenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings CallRelease
Glenmark Pharmaceuticals Limited on 6ix
Earlier from Glenmark Pharmaceuticals
- Press Release Mar 16 2023
- Press Release Mar 14 2023
- Press Release Mar 09 2023
- Press Release Feb 17 2023
- Press Release Jan 23 2023
Later from Glenmark Pharmaceuticals
- Glenmark Pharmaceuticals Limited Press Release Mar 23 2023
- Press Release May 19 2023
- Press Release Aug 01 2023
- Glenmark Pharmaceuticals Limited Press Release Aug 17 2023
- Press Release Sep 21 2023
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals